Pluri Inc. Increase (Decrease) in Restricted Cash and Investments
Pluri Inc. (PLUR) reported Increase (Decrease) in Restricted Cash and Investments of -$777.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashAndInvestments · last filed 2018-11-07
- Pluri Inc. increase (decrease) in restricted cash and investments for the quarter ending 2018-09-30 was -$777.00K.
- Pluri Inc. increase (decrease) in restricted cash and investments for the quarter ending 2017-09-30 was -$599.00K.
- Pluri Inc. increase (decrease) in restricted cash and investments for the quarter ending 2014-06-30 was -$5.00K.
- Pluri Inc. increase (decrease) in restricted cash and investments for the quarter ending 2014-03-31 was -$1.00K.
- Pluri Inc. increase (decrease) in restricted cash and investments for fiscal 2014 was -$122.00K.
- Pluri Inc. increase (decrease) in restricted cash and investments for fiscal 2013 was -$869.00K.
- Pluri Inc. increase (decrease) in restricted cash and investments for fiscal 2012 was -$6.00K.
| Period end | Increase (Decrease) in Restricted Cash and Investments 3 month | Increase (Decrease) in Restricted Cash and Investments 6 month | Increase (Decrease) in Restricted Cash and Investments 9 month | Increase (Decrease) in Restricted Cash and Investments 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$777.00K 10-Q · filed 2018-11-07 | |||
| 2017-09-30 | -$599.00K 10-Q · filed 2018-11-07 | |||
| 2014-06-30 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11 | -$6.00K derived: sum of 2 quarters · filed 2015-05-06 | -$10.00K derived: sum of 3 quarters · filed 2015-05-06 | -$122.00K 10-K · filed 2014-09-11 |
| 2014-03-31 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | -$5.00K derived: sum of 2 quarters · filed 2015-05-06 | -$117.00K 10-Q · filed 2015-05-06 | -$974.00K derived: sum of 4 quarters · filed 2015-05-06 |
| 2013-12-31 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | -$116.00K 10-Q · filed 2015-02-05 | -$973.00K derived: sum of 3 quarters · filed 2015-02-05 | |
| 2013-09-30 | -$112.00K 10-Q · filed 2014-11-06 | -$969.00K derived: sum of 2 quarters · filed 2014-11-06 | ||
| 2013-06-30 | -$857.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11 | -$869.00K 10-K · filed 2014-09-11 | ||
| 2013-03-31 | -$12.00K 10-Q · filed 2014-05-08 | |||
| 2012-06-30 | -$6.00K 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |